NCT06695039View on ClinicalTrials.gov

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions
Breast Cancer Invasive
Interventions
DIAGNOSTIC_TEST

Fluoroestradiol (18F)

images for 90 minutes after F-18 FES injection

Trial Locations (1)

Unknown

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER